Stay updated on Pembrolizumab and Binimetinib in TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FLwszMTIChW0iDb84KJhRunKVKUo.uncropped.jpg&w=3840&q=75)
Latest updates to the Pembrolizumab and Binimetinib in TNBC Clinical Trial page
- Check7 days agoChange DetectedThe website has updated its results section by removing estimated timestamps and now displays the actual 'Results First Posted' and 'Last Update Posted' dates.SummaryDifference0.1%
- Check14 days agoChange DetectedThe latest update on the study includes the posting of results regarding the Maximum Tolerated Dose (MTD) of Pembrolizumab in combination with Binimetinib, along with detailed methodologies for assessing Objective Response Rate (ORR) and Progression Free Survival (PFS), while previous submissions and updates have been removed.SummaryDifference5%
- Check21 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe website has been updated to version v2.10.0, adding 3 more conditions and indicating that the study now has 1 location, while the previous version v2.9.7 has been removed.SummaryDifference0.4%
- Check49 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check63 days agoChange DetectedThe web page value for Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the page.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab and Binimetinib in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.